Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/20/23 04:50:00 on US and Canada Markets.
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 MANIFEST-2 met primary endpoint, nearly doubling SVR35 response rate (66% versus 35%) The key secondary endpoints assessing symptom reduction, TSS50 and absolute change in TSS, showe...
Topline Phase 2b data expected in June 2024 More than 120 sites around the world actively recruiting in the Phase 3 portion of the IMPAHCT trial WALTHAM, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company...
MIAMI BEACH, FL / ACCESSWIRE / November 20, 2023 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), a leading marketing agency specializing in the spirits and beverage industry, provides an update on the progression of its Share Buyback Program. This Share Buyback Program is a direct ...
SAN DIEGO, CA and TAICANG, China, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inf...
2023-11-20 16:40:00 ET Dividend investing started gathering momentum after the tech bubble burst in the first half of 2022. The way the stock market works, growth stocks rise when the economy grows, and dividend stocks are in demand when the economy is weak. The trend of dividend inve...
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12 th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York Cit...
HOLLISTON, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12 th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York Cit...
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study PR Newswire TEL AVIV, Israel , Nov. 20, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmace...
LODI, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Farmers & Merchants Bancorp (OTCQX: FMCB ) (the “Company” or “FMCB”), the parent company of Farmers & Merchants Bank of Central California (the “Bank” or “F&M Bank”), announ...
Halifax, Nova Scotia--(Newsfile Corp. - November 20, 2023) - Torrent Capital Ltd. (TSXV: TORR) ("Torrent") is pleased to provide a corporate update on its 50/50 joint venture company, Argentia Capital Inc. (" ACI ") with Port of Argentia Inc. (" POA "), as announced on September 21, 2022, and a...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
12.03%Change Percent:
Enveric Biosciences Inc Com Company Name:
ENVB Stock Symbol:
NASDAQ Market:
enveric.com Website: